Granisetron Market
Granisetron Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Granisetron Market Size and Growth
The Granisetron market is experiencing steady growth, driven by increasing cases of nausea and vomiting related to chemotherapy and surgery. The global market size is estimated to reach approximately $1.2 billion by 2026, with a compound annual growth rate of around 5%. Key market dynamics include rising awareness and advanced formulations.
Companies Covered
(Covid 19 Impact Covered)
◍ Kyowa Kirin
◍ Heron Therapeutics
◍ Fresenius Kabi
◍ Hikma Pharmaceuticals
◍ Teva
◍ Cipla
◍ Sandoz
◍ Wockhardt
◍ Mylan
◍ APOTEX
◍ Dr.Reddy's
◍ Bluepharma
◍ Natco Pharma
◍ Akorn
◍ Taro Pharmaceutical
◍ Aurobindo
The Granisetron market benefits from companies like Kyowa Kirin and Heron Therapeutics through innovative formulations. Fresenius Kabi and Hikma Pharmaceuticals enhance distribution, while Teva and Cipla drive generic competition. Sales figures for key players highlight the market's growth potential: Kyowa Kirin ($1 billion), Teva ($16 billion), Mylan ($11 billion).
Request Sample Report
Market Segmentation
By Application
Chemotherapy
Post operative
Request Sample Report
By Product
Transdermal system
Injection
Oral
Market Growth
Request Sample Report
$ 9.44 Billion
